- Home
- CWEN vs LIVN Comparison
CWEN vs LIVN Comparison
Compare CWEN & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWEN
- LIVN
- Stock Information
- Founded
- CWEN 2012
- LIVN 1987
- Country
- CWEN United States
- LIVN United Kingdom
- Employees
- CWEN N/A
- LIVN N/A
- Industry
- CWEN Electric Utilities: Central
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CWEN Utilities
- LIVN Health Care
- Exchange
- CWEN Nasdaq
- LIVN Nasdaq
- Market Cap
- CWEN 3.1B
- LIVN 2.8B
- IPO Year
- CWEN 2013
- LIVN 1993
- Fundamental
- Price
- CWEN $26.30
- LIVN $47.06
- Analyst Decision
- CWEN Buy
- LIVN Buy
- Analyst Count
- CWEN 8
- LIVN 7
- Target Price
- CWEN $31.63
- LIVN $67.14
- AVG Volume (30 Days)
- CWEN 763.1K
- LIVN 548.5K
- Earning Date
- CWEN 02-20-2025
- LIVN 02-19-2025
- Dividend Yield
- CWEN 6.45%
- LIVN N/A
- EPS Growth
- CWEN 124.49
- LIVN 759.09
- EPS
- CWEN 1.04
- LIVN 0.43
- Revenue
- CWEN $1,364,000,000.00
- LIVN $1,241,739,000.00
- Revenue This Year
- CWEN $9.13
- LIVN $10.10
- Revenue Next Year
- CWEN $7.39
- LIVN $5.43
- P/E Ratio
- CWEN $25.39
- LIVN $110.21
- Revenue Growth
- CWEN 2.33
- LIVN 11.04
- 52 Week Low
- CWEN $20.63
- LIVN $43.15
- 52 Week High
- CWEN $30.92
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- CWEN 38.78
- LIVN 33.80
- Support Level
- CWEN $25.57
- LIVN $46.44
- Resistance Level
- CWEN $26.55
- LIVN $49.32
- Average True Range (ATR)
- CWEN 0.63
- LIVN 1.44
- MACD
- CWEN -0.14
- LIVN -0.39
- Stochastic Oscillator
- CWEN 21.28
- LIVN 16.44
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into conventional power generation, renewables and thermal divisions.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.